<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>OMACETAXINE MEPESUCCINATE - Research Report</title>
    <meta name="description" content="Comprehensive naturopathic research report for OMACETAXINE MEPESUCCINATE">
    <style>

    * {
        box-sizing: border-box;
    }

    body {
        font-family: 'Segoe UI', 'Helvetica Neue', Arial, sans-serif;
        font-size: 16px;
        line-height: 1.6;
        margin: 0;
        padding: 0;
        background-color: #f8f9fa;
        color: #212529;
    }

    .container {
        max-width: 1200px;
        margin: 0 auto;
        padding: 20px;
        background-color: white;
        box-shadow: 0 0 10px rgba(0,0,0,0.1);
    }

    .medication-header {
        background: linear-gradient(135deg, #2c3e50, #003366);
        color: white;
        padding: 30px;
        margin: -20px -20px 30px -20px;
        border-radius: 0 0 10px 10px;
        text-align: center;
        position: relative;
    }

    .medication-header h1 {
        margin: 0 0 15px 0;
        font-size: 2.5em;
        font-weight: 600;
        text-shadow: 0 2px 4px rgba(0,0,0,0.3);
    }

    .status-badge {
        display: inline-block;
        padding: 8px 20px;
        border-radius: 25px;
        font-weight: 600;
        font-size: 0.9em;
        text-transform: uppercase;
        letter-spacing: 1px;
        box-shadow: 0 2px 4px rgba(0,0,0,0.2);
    }

    .status-allowed { background-color: #28a745; color: white; }
    .status-not-allowed { background-color: #dc3545; color: white; }
    .status-modernization { background-color: #fd7e14; color: white; }
    .status-topical { background-color: #20c997; color: white; }
    .status-review { background-color: #ffc107; color: #212529; }
    .status-not-applicable { background-color: #6c757d; color: white; }
    .status-unknown { background-color: #adb5bd; color: white; }

    .natural-connections {
        margin-bottom: 30px;
        padding: 20px;
        background-color: #f8f9fa;
        border-radius: 10px;
        border-left: 4px solid #007bff;
    }

    .natural-connections h2 {
        margin: 0 0 15px 0;
        font-size: 1.4em;
        color: #2c3e50;
    }

    .connection-tags {
        display: flex;
        flex-wrap: wrap;
        gap: 8px;
    }

    .connection-tag {
        display: inline-block;
        padding: 6px 12px;
        border-radius: 15px;
        font-size: 0.85em;
        font-weight: 500;
        color: white;
        white-space: nowrap;
    }

    .tag-direct { background-color: #0d6832; }
    .tag-semi-synthetic { background-color: #198754; }
    .tag-structural { background-color: #0d6efd; }
    .tag-endogenous { background-color: #6610f2; }
    .tag-biosynthetic { background-color: #6f42c1; }
    .tag-pathways { background-color: #0dcaf0; color: #212529; }
    .tag-processes { background-color: #3dd5f3; color: #212529; }

    .report-content {
        line-height: 1.7;
    }

    .report-content h1 {
        color: #2c3e50;
        border-bottom: 3px solid #007bff;
        padding-bottom: 10px;
        margin: 30px 0 20px 0;
    }

    .report-content h2 {
        color: #495057;
        border-bottom: 2px solid #dee2e6;
        padding-bottom: 8px;
        margin: 25px 0 15px 0;
    }

    .report-content h3 {
        color: #6c757d;
        margin: 20px 0 10px 0;
    }

    .report-content p {
        margin-bottom: 15px;
        text-align: justify;
    }

    .checkbox {
        font-weight: bold;
        margin-right: 5px;
    }

    .checkbox.checked { color: #28a745; }
    .checkbox.unchecked { color: #6c757d; }

    .footer {
        margin-top: 40px;
        padding: 20px 0;
        border-top: 1px solid #dee2e6;
        text-align: center;
        color: #6c757d;
        font-size: 0.9em;
    }

    .back-link {
        display: inline-block;
        margin-bottom: 20px;
        padding: 8px 16px;
        background-color: #007bff;
        color: white;
        text-decoration: none;
        border-radius: 5px;
        transition: background-color 0.3s;
    }

    .back-link:hover {
        background-color: #0056b3;
        text-decoration: none;
    }

    @media (max-width: 768px) {
        .container {
            padding: 15px;
            margin: 10px;
        }
        .medication-header {
            margin: -15px -15px 20px -15px;
            padding: 20px;
        }
        .medication-header h1 {
            font-size: 2em;
        }
        .connection-tags {
            justify-content: center;
        }
    }

    @media print {
        .back-link { display: none; }
        .container { box-shadow: none; }
        .medication-header {
            background: #2c3e50 !important;
            -webkit-print-color-adjust: exact;
        }
    }

    </style>
</head>
<body>
    <div class="container">
        <a href="index.html" class="back-link">← Back to Index</a>

        <header class="medication-header">
            <h1>OMACETAXINE MEPESUCCINATE</h1>
            <div class="status-badge status-modernization">
                TARGET_FOR_MODERNIZATION
            </div>
        </header>

        <section class="natural-connections">
            <h2>Natural Connections</h2>
            <div class="connection-tags">
                <span class="connection-tag tag-direct">Direct Natural</span>
<span class="connection-tag tag-semi-synthetic">Semi-Synthetic</span>
<span class="connection-tag tag-structural">Structural Analog</span>
<span class="connection-tag tag-pathways">Works Natural Pathways</span>
<span class="connection-tag tag-processes">Facilitates Natural Processes</span>
            </div>
        </section>

        <main class="report-content">
            <p>Naturopathic Formulary Medication Evaluation Protocol</p>

<p># Objective: Comprehensive assessment of natural derivation and therapeutic alignment For <strong>OMACETAXINE MEPESUCCINATE</strong>:</p>

<strong>Evidence Categories Present:</strong>

<span class="checkbox checked">✓</span> Direct natural source <span class="checkbox checked">✓</span> Semi-synthetic from natural precursor <span class="checkbox checked">✓</span> Structural analog of natural compound <span class="checkbox unchecked">☐</span> Endogenous compound or replacement <span class="checkbox unchecked">☐</span> Biosynthetic/fermentation product <span class="checkbox checked">✓</span> Works through natural pathways/receptors <span class="checkbox checked">✓</span> Facilitates natural physiological processes <span class="checkbox unchecked">☐</span> No identified natural connection

<h2>1. NATURAL DERIVATION ASSESSMENT</h2>

<p>### <h3>Source Investigation</h3> OMACETAXINE MEPESUCCINATE is derived from natural sources. Omacetaxine mepesuccinate is a semi-synthetic derivative of homoharringtonine, an alkaloid naturally occurring in the evergreen tree Cephalotaxus harringtonia (Japanese plum yew) and other Cephalotaxus species. The compound was developed through pharmaceutical research. derivation from Cephalotaxus alkaloids with well-documented traditional medicine use. The compound works through evolutionarily conserved cellular mechanisms and integrates with natural physiological processes for cell cycle regulation and apoptosis. Evidence strongly supports both direct natural origin and integration with natural biological systems. <p><strong><strong>Relevant Citations:</strong></strong></p></p>

<ol>

<li>DrugBank. &quot;Omacetaxine mepesuccinate&quot; DrugBank Accession Number DB06803. Updated 2024. Available at: https://go.drugbank.com/drugs/DB06803 2. U.S. Food and Drug Administration. &quot;SYNRIBO (omacetaxine mepesuccinate) for injection, for subcutaneous use. Prescribing Information.&quot; Initial approval October 2012, Updated 2019.</li>

<li>Powell RG, Weisleder D, Smith CR Jr, Rohwedder WK. &quot;Structures of harringtonine, isoharringtonine, and homoharringtonine.&quot; Tetrahedron Letters. 1970;11(10):815-818.</li>

<li>Chen R, Gao L, Chen Y, et al. &quot;Homoharringtonine reduced Mcl-1 expression and induced apoptosis in chronic lymphocytic leukemia.&quot; Blood. 2011;117(1):156-164.</li>

<li>Fresno M, Jiménez A, Vázquez D. &quot;Inhibition of translation in eukaryotic systems by harringtonine.&quot; European Journal of Biochemistry. 1977;72(2):323-330.</li>

<li>PubChem. &quot;Omacetaxine mepesuccinate&quot; PubChem CID 9941444. National Library of Medicine. Available at: https://pubchem.ncbi.nlm.nih.gov/compound/9941444 7. Cortes JE, Nicolini FE, Wetzler M, et al. &quot;Subcutaneous omacetaxine mepesuccinate in patients with chronic-phase chronic myeloid leukemia previously treated with 2 or more tyrosine kinase inhibitors including imatinib.&quot; Blood. 2013;122(13):2473-2480.</li>

<li>Zhou JY, Chen DL, Shen ZS, et al. &quot;Effect of homoharringtonine on cash-1 gene expression in patients with chronic myelogenous leukemia.&quot; Chinese Medical Journal. 1995;108(12):885-889.</li>

<li>Kantarjian HM, O&#x27;Brien S, Cortes J. &quot;Homoharringtonine/omacetaxine mepesuccinate: the natural derivative that made it to drug approval.&quot; Expert Opinion on Pharmacotherapy. 2013;14(2):213-218.</li>

<li>Lü S, Wang J. &quot;Homoharringtonine and omacetaxine for myeloid hematological malignancies.&quot; Journal of Hematology &amp; Oncology. 2014;7:2.</li>

</ol>
        </main>

        <footer class="footer">
            <p>Generated on September 24, 2025 at 07:19 AM</p>
        </footer>
    </div>
</body>
</html>